Scott C Jeffrey

This inventor holds 30 USPTO granted patents and 12 published patent applications, plus 10 CIPO patents and 13 EPO patents, primarily in Antibody Drug Conjugates. Top assignees: Seattle Genetics, Inc., Medimmune Limited, Seagen Inc.. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott C Jeffrey. Retrieved from https://idiyas.com/inventor/scott-c-jeffrey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 12)

% Patents Active = 96.7

CIPO Patents = 10 (Patent Applications = 8)

EPO Patents = 13 (Patent Applications = 19)

Average Co-Inventor Count = 2.9

ph-index = 14

Forward Citations = 669(Granted Patents)

Location History:

London, GB (2017)
Snohomish, WA (US) (2009 - 2021)
Bothell, WA (US) (2012 - 2022)

Company Filing History:

26 out of 132

Seattle Genetics, Inc.

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

Anti-PD-L1 Antibodies

Antibody-Drug Conjugates

Camptothecin Conjugates

CD33 Antibodies

Pyrrolobenzodiazepines

Beta-Glucuronide-Linker

Methylene Carbamate Linkers

Fucosylation Reduction

Proliferative Diseases

Targeted Conjugates

Monomethylvaline Compounds

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421312 - Anti-PD-L1 antibodies and antibody-drug conjugates (2025-09-23),

2. 12194321 - Camptothecin conjugates (2025-01-14),

3. 11319526 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation (2022-05-03),

4. 11116847 - Methylene carbamate linkers for use with targeted-drug conjugates (2021-09-14),

5. 10787514 - CD33 antibodies and use of same to treat cancer (2020-09-29),

6. 10561739 - Targeted pyrrolobenzodiazapine conjugates (2020-02-18),

7. 10443035 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation (2019-10-15),

8. 10329352 - Pyrrolobenzodiazepines and targeted conjugates (2019-06-25),

9. 10328084 - Pyrrolobenzodiazepines and targeted conjugates (2019-06-25),

10. 9816069 - Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation (2017-11-14),

11. 9732084 - Pyrrolobenzodiazepines used to treat proliferative diseases (2017-08-15),

12. 9731030 - β-glucuronide-linker drug conjugates (2017-08-15),

13. 9713647 - Pyrrolobenzodiazepines and targeted conjugates (2017-07-25),

14. 9707301 - Pyrrolobenzodiazepines and targeted conjugates (2017-07-18),

15. 9592240 - Targeted pyrrolobenzodiazapine conjugates (2017-03-14),

Title: The Inventive Journey of Scott C Jeffrey

Introduction: Scott C Jeffrey is a prolific inventor based in Bothell, Washington. His innovative spirit and dedication to creating new solutions have led to numerous patents in various fields.

Latest Patents: Scott C Jeffrey's latest patents include advancements in renewable energy technologies, medical devices, and consumer electronics. His commitment to pushing the boundaries of innovation is evident in the diverse range of his recent inventions.

Career Highlights: With a background in engineering and a passion for problem-solving, Scott C Jeffrey has had a successful career marked by groundbreaking inventions. His ability to identify gaps in the market and develop unique solutions has set him apart in the world of innovation.

Collaborations: Throughout his career, Scott C Jeffrey has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in turning his ideas into tangible products that have made a positive impact on various industries.

Conclusion: Scott C Jeffrey's journey as an inventor is a testament to the power of creativity and perseverance in driving progress and shaping the future. His contributions to innovation continue to inspire the next generation of inventors to think outside the box and pursue their ideas with passion and determination.

Profile summary based on public USPTO records.